Prosecution Insights
Last updated: April 19, 2026

Galecto Biotech AB

4 pending office actions

Portfolio Summary

4
Total Pending OAs
2
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18259146 NOVEL GALACTOSIDE INHIBITOR OF GALECTINS CREWS, JARET JAMES 1691 Non-Final OA Jun 23, 2023
18258656 NOVEL GALACTOSIDE INHIBITOR OF GALECTINS LEWIS, PATRICK T 1691 Non-Final OA Jun 21, 2023
17785295 LARGE SCALE PROCESS BERRY, LAYLA D 1693 Final Rejection Jun 14, 2022
17415314 AMORPHOUS FORM OF 5-BROMOPYRIDIN-3-YL 3-DEOXY-3-[4-(3,4,5-TRIFLUOROPHENYL)-1H-1,2,3-TRIAZOL-1-YL]-1-THIO-ALPHA-D-GALACTOPYRANOSIDE BERRY, LAYLA D 1693 Final Rejection Jun 17, 2021

Managing Galecto Biotech AB's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month